Bausch & Lomb to acquire medical device company eyeonics, inc.
Posted: Monday, January 21, 2008
ROCHESTER, N.Y. (AP) -- Bausch & Lomb announced Sunday that the eye health company plans to acquire eyeonics, inc., a privately held California company that makes a special lens used in cataract repair.
Rochester-based Bausch & Lomb did not disclose financial terms. The transaction is expected to close in the first quarter.
Eyeonics is based in Aliso Viejo, Calif.
Once acquired, eyeonics will be wrapped into Bausch & Lomb's surgical business, the company said. The U.S. surgical business will be led by J. Andy Corley, eyeonics' co-founder, chairman and chief executive officer, it said.
Eyeonics, founded in 1998, developed and markets the crystalens intraocular lens, which has been approved by the U.S. Food and Drug Administration for the treatment of cataracts. The intraocular lens replaces the eye's natural lens and has been implanted in more than 95,000 eyes worldwide.
In 2007, eyeonics generated revenues of approximately $34 million.
Bausch & Lomb has been in business more than 150 years. The company makes contact lenses, ophthalmic drugs and vision-correction surgical instruments.
In May 2006 the company was rocked by the worldwide recall of a lens solution blamed for a flurry of potentially blinding fungal infections. The company has said it was named as a defendant in more than 550 product-liability lawsuits stemming from the recall.
Federal regulators called the $100 million-a-year ReNu with MoistureLoc multipurpose cleaner the "potential root cause" of an outbreak of Fusarium keratitis infections in the United States, Asia and other parts of the world.
Rochester-based Bausch & Lomb did not disclose financial terms. The transaction is expected to close in the first quarter.
Eyeonics is based in Aliso Viejo, Calif.
Once acquired, eyeonics will be wrapped into Bausch & Lomb's surgical business, the company said. The U.S. surgical business will be led by J. Andy Corley, eyeonics' co-founder, chairman and chief executive officer, it said.
Eyeonics, founded in 1998, developed and markets the crystalens intraocular lens, which has been approved by the U.S. Food and Drug Administration for the treatment of cataracts. The intraocular lens replaces the eye's natural lens and has been implanted in more than 95,000 eyes worldwide.
In 2007, eyeonics generated revenues of approximately $34 million.
Bausch & Lomb has been in business more than 150 years. The company makes contact lenses, ophthalmic drugs and vision-correction surgical instruments.
In May 2006 the company was rocked by the worldwide recall of a lens solution blamed for a flurry of potentially blinding fungal infections. The company has said it was named as a defendant in more than 550 product-liability lawsuits stemming from the recall.
Federal regulators called the $100 million-a-year ReNu with MoistureLoc multipurpose cleaner the "potential root cause" of an outbreak of Fusarium keratitis infections in the United States, Asia and other parts of the world.
Story Comments
Read More and Post Comments 0 comment(s)
Please note: The following are comments from readers. In no way do they represent the views of The Sioux City Journal or Lee Enterprises. We will not edit or alter your comments, but we do reserve the right to not post or to remove comments that violate our code of conduct. No comment may contain potentially libelous statements; obscene, explicit or racist language; personal attacks, insults or threats. Terms of Service
